NTUS Past Earnings image   This NTUS past earnings page last updated 8/17/2022
NTUS Past Earnings
PeriodPast Earnings DateAdj. EPS
Q1 20225/5/20220.220
Q4 20212/24/20220.470
Q3 202111/4/20210.280
Q2 20218/5/20210.290
Q1 20215/6/20210.160
Q4 20202/25/20210.390
Q3 202010/29/20200.090
Q2 20207/30/2020-0.130
Q1 20204/30/20200.040
Q4 20192/6/20200.460
Q3 201910/24/20190.360
Q2 20197/25/20190.340
Q1 20194/25/20190.090
Q4 20182/13/20190.43
Q3 201810/24/20180.4
Q2 20187/25/20180.35
Q1 20184/25/20180.24
Q4 20172/7/20180.42
Q3 201710/25/20170.4
Q2 20177/26/20170.34
Q1 20174/26/20170.3
Q4 20162/1/20170.51
Q3 201610/19/20160.39
Q2 20167/20/20160.39
Q1 20164/20/20160.34
Q4 20151/27/20160.51
Q3 201510/21/20150.39
Q2 20157/22/20150.34
Q1 20154/22/20150.31
Q4 20141/28/20150.4
Q3 201410/22/20140.33
Q2 20147/23/20140.28
Q1 20144/23/20140.19
Q4 20131/29/20140.37
Q3 201310/24/20130.3
Q2 20138/1/20130.21
Q1 20134/26/20130.11
Q4 20122/28/20130.29
Q3 201211/7/20120.15
Q2 20127/26/20120.12
Q1 20124/26/20120.07
NTUS Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/5/20220.12B
Q4 20212/24/20220.13B
Q3 202111/4/20210.11B
Q2 20218/5/20210.12B
Q1 20215/6/20210.11B
Q4 20202/25/20210.12B
Q3 202010/29/20200.10B
Q2 20207/30/20200.08B
Q1 20204/30/20200.11B
Q4 20192/6/20200.13B
Q3 201910/24/20190.12B
Q2 20197/25/20190.13B
Q1 20194/25/20190.11B
Q4 20182/13/20190.14B
Q3 201810/24/20180.13B
Q2 20187/25/20180.13B
Q1 20184/25/20180.13B
Q4 20172/7/20180.13B
Q3 201710/25/20170.12B
Q2 20177/26/20170.12B
Q1 20174/26/20170.12B
Q4 20162/1/20170.11B
Q3 201610/19/20160.09B
Q2 20167/20/20160.10B
Q1 20164/20/20160.09B
Q4 20151/27/20160.10B
Q3 201510/21/20150.09B
Q2 20157/22/20150.09B
Q1 20154/22/20150.09B
Q4 20141/28/20150.09B
Q3 201410/22/20140.09B
Q2 20147/23/20140.09B
Q1 20144/23/20140.09B
Q4 20131/29/20140.09B
Q3 201310/24/20130.09B
Q2 20138/1/20130.08B
Q1 20134/26/20130.09B
Q4 20122/28/20130.09B
Q3 201211/7/20120.08B
Q2 20127/26/20120.06B
Q1 20124/26/20120.06B
Quotes delayed 20 minutes

Email EnvelopeFree NTUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Natus Medical (NTUS) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

NURO Past Earnings
NUVA Past Earnings
NUVL Past Earnings
NUWE Past Earnings
NVAX Past Earnings
NVIV Past Earnings
NVNO Past Earnings
NVOS Past Earnings
NVRO Past Earnings
NVST Past Earnings

NTUS Past Earnings Q&A

What was the best and worst NTUS past earnings results?
For Natus Medical, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest NTUS past earnings result in our data set was 0.51/share posted in Q4 2016, while the lowest was in Q2 2020 when NTUS posted -0.130/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q4 2018 when NTUS reported 0.14B in revenue, while the quarter with the lowest revenue in our data set was Q1 2012 at 0.06B of revenue.

  Suggested answer: There are 41 NTUS past earnings results in our data set.

On this page we presented the NTUS past earnings date information for Natus Medical. Reviewing that NTUS Past Earnings for the company, we see that the highest past earnings result in our data set was in Q4 2016, when NTUS posted adjusted EPS of 0.51/share. Meanwhile the lowest NTUS past earnings result was in Q2 2020, when NTUS posted adjusted EPS of -0.130/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q4 2018 when NTUS reported 0.14B in revenue, while the smallest revenue quarter was Q1 2012 when NTUS reported 0.06B in revenue.

Any self directed investor doing their due diligence on NTUS or any other given stock can benefit from researching all of the Natus Medical past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Natus Medical past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NTUS. Thanks for visiting, and the next time you need to research NTUS past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: NOK Videos, Funds Holding GEEX, FXNC Average Annual Return.


NTUS Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.